takeda pharmaceutical co ltd (4502) Details

Takeda Pharmaceutical Company Limited, a research-based pharmaceutical company, engages in the manufacture, marketing, and import/export of pharmaceutical drugs worldwide. It provides products in the therapeutic areas of allergy, cardiovascular, central nervous system, diabetes, gastrointestinal, gout, infection, inflammation, interleukin, oncology, osteoporosis, and urology and gynecology, as well as offers vaccines and vitamins. The company’s cardiovascular and metabolic drugs comprise pioglitazone hydrochloride and alogliptin benzoate for type 2 diabetes; and candesartan cilexetil and azilsartan for hypertension. Its central nervous system drugs consist of ramelteon for insomnia and galantamine hydrobromide for alzheimer’s-type dementia; and respiratory and immunology drugs comprise roflumilast for chronic obstructive pulmonary disease, and colchicine and febuxostat for hyperuricemia and gout. The company’s oncology drugs include bortezomib for multiple myeloma; leuprorelin acetate for prostate cancer, breast cancer, and endometriosis; and panitumumab for cancer. It also offers general medicines comprising lansoprazole for peptic ulcer; dexlansoprazole for acid reflux disease; and peginesatide for anemia due to chronic kidney disease. In addition, the company offers over-the-counter drugs, including cold remedies, gastrointestinal drugs, vitamin products, vitamin-containing tonics, athlete's foot treatments, and laxatives. Further, it is involved in the production and sale of reagents, clinical diagnostics, and chemical products. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Osaka, Japan.

takeda pharmaceutical co ltd (4502) Top Compensated Officers